Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn's Disease. Ferru-Clement R, Boucher G, Forest A, Bouchard B, et al. Inflamm Bowel Dis 2023 Jan 20:izac281. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Ferru-Clement R, Boucher G, Forest A, Bouchard B, et al. Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn's Disease. Inflamm Bowel Dis 2023 Jan 20:izac281. doi: 10.1093.
PMID: 36662167